Atlas Trials

Study to Evaluate the Efficacy and Safety of Tocilizumab Versus Corticosteroids in Hospitalised COVID-19 Patients With High Risk of Progression

Clinical trial NCT04345445 · UNKNOWN

Trial details

NCT number
NCT04345445
Sponsor
University of Malaya
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-04-15
Primary completion
2020-10-31
Enrollment
310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.